Dr. Muzamil Ahmad received his master's and Ph.D. in Toxicology from Hamdard University in 2003. Following his doctoral studies, he completed seven years of postdoctoral research at institutions including Johns Hopkins University and the University of Pittsburgh in the United States. In 2010, Dr. Ahmad joined the CSIR-Indian Institute of Integrative Medicine, where he currently holds the position of Scientist F. His research is centered on elucidating the molecular mechanisms underlying neurodegeneration and regeneration, with a particular emphasis on stroke, Parkinson’s disease, and Alzheimer’s disease, utilizing both in vivo and in vitro models. The primary objective of his laboratory is to identify strategies to slow the progression of neurodegenerative diseases and to develop novel therapeutic approaches. His team also generates molecular evidence supporting the therapeutic potential of AYUSH-complementary and alternative medicines in neurodegenerative disorders and pain management. Dr. Ahmad has published 52 research articles in peer-reviewed journals, accumulating 4,900 citations and an h-index of 35. He serves on several international reviewer panels and editorial boards of leading journals in his field. In recognition of his scientific contributions, Dr. Ahmad has received the Ramalingaswamy Fellowship from the Department of Biotechnology (DBT), Government of India, and has been conferred the Distinguished Alumnus Award by Hamdard University, New Delhi.